Skip Navigation
Skip to contents

ICKSH 2024

D-31 2024-04-28

Abstract Guidelines

Abstract Papers

We invite you to submit papers. Accepted papers will be presented at the ICKSH 2024 as either Oral session or Posters.

Important Dates

  • First Notification of
    Abstract AcceptanceClosed
  • Second Notification of
    Abstract Acceptance by Jan 19, 2024 (KST)
  • Deadline for
    Early-bird Registrationby Feb 28, 2024 (KST)

ABSTRACT CATEGORY

  • Acute Lymphoblastic Leukemia
  • Lymphoma
  • Acute Myeloid Leukemia
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Platelet/Hemostasis
  • Anemia and Other Red Cell Disorders
  • Cellular Therapy
  • Bone Marrow Failure Syndromes
  • Hematopoiesis/Stem Cell Biology
  • Chronic Myeloid Leukemia
  • Hematopoietic Stem Cell Transplantation
  • Myeloproliferative Neoplasm
  • Laboratory Hematology
  • Histiocytosis and Other Dendritic Cell Neoplasm
  • Quality of Life
  • Transfusion Medicine
  • Others

Abstract Submission Process

We invite you to submit papers. Accepted papers will be presented at the ICKSH 2024 as either Oral session or Posters.

  • STEP 01 Sign-up or Log in Click the “Online Abstract Submission“ button
  • STEP 02 Fill out the author information and abstract form Please write down your contact details clearly
  • STEP 03 Preview and submit the abstract You can modify and print your abstract on my page
  • STEP 04 Check your email for acceptance notification
  • STEP 05 Check your email for final acceptance Notice
Title - Capitalize the first letter of each word
- Limited to 150 letters including spaces
Author Information - Name: Write first and family name(s) in full.
- Affiliation should be structured as follows: Department, Institution, Country
- Degrees or titles such as MD after an author’s name must be deleted.
Abstract Body - Structured chronologically into four sections: Background, Methods, Results, Conclusions
- Limited to 300 words including spaces and punctuation
Keywords No more than 5 keywords which the first word begins with a capital letter.
Tables and Images Only one Table or image is allowed.

Notification of Acceptance

  • All submitted abstracts will be reviewed by the Scientific Committee according to reviewing procedures.
  • Notification of acceptance will be sent by e-mail to corresponding and presenting authors by Jan 19, 2024 (KST).

Withdrawal of abstracts

  • If the presenting author of an accepted abstract does not register by end of January ,2024 (KST), the abstract will be automatically withdrawn from the final program.
  • If you must withdraw an abstract, please notify the ICKSH 2024 Secretariat in writing as soon as possible. (icksh@icksh.org)

Go top

Hosted by
  • The Korea Society of Hematology
Supported by
  • 한국관광공사
  • 서울특별시

Sponsored by

ICKSH2024 Secretariat: People-X, Inc.
1F, Haeoreum B/D 16, Yeoksam-ro 17 gil, Yeoksam-dong, Gangnam-gu, Seoul 06246, Korea

Tel: +82-2-566-6031/6033|Fax: +82-2-566-6087| E-mail: icksh@icksh.org

President (대표자) : Seongsoo Jang (장성수)|Business license (사업자등록번호) : 205-82-63080